Ketamine for pain

F1000Research

Volumn 6, Issue , 2017, Pages

  Dahan, Albert ^a   Jonkman, Kelly ^a   van de Donk, Tine ^a   Aarts, Leon ^a   Niesters, Marieke ^a   van Velzen, Monique ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Analgesia; Ketamine; Pain; Postoperative pain

Indexed keywords

CIBINETIDE; KETAMINE; PLACEBO;

ANALGESIC ACTIVITY; CANCER PAIN; COMPLEX REGIONAL PAIN SYNDROME; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYDROXYLATION; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG RESPONSE; HALLUCINATION; HEMORRHAGIC CYSTITIS; HEPATITIS; HUMAN; LIPOPHILICITY; LOW DRUG DOSE; NAUSEA AND VOMITING; NEUROPATHIC PAIN; PAIN ASSESSMENT; PANIC; PARANOIA; PERIPHERAL NERVE INJURY; POSTOPERATIVE PAIN; REVIEW; SPINAL CORD INJURY; TREATMENT DURATION; TREATMENT OUTCOME; WHIPLASH INJURY;

EID: 85029813926     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.11372.1     Document Type: Review

References (52)

1. Li L Vlisides PE: Ketamine: 50 Years of Modulating the Mind. Front Hum Neurosci. 2016;10:612. 27965560 10.3389/fnhum.2016.00612 5126726 F1000 Recommendation
2. Niesters M Martini C Dahan A: Ketamine for chronic pain: risks and benefits. Br J Clin Pharmacol. 2014;77(2):357-67. 23432384 10.1111/bcp.12094 4014022
3. Singh JB Fedgchin M Daly E: Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. Biol Psychiatry. 2016;80(6):424-31. 26707087 10.1016/j.biopsych.2015.10.018 F1000 Recommendation
4. Swartjes M Niesters M Heij L: Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131). PLoS One. 2013;8(8):e71326. 23936499 10.1371/journal.pone.0071326 3731332
5. Jonkman K van de Donk T Dahan A: Ketamine for cancer pain: what is the evidence? Curr Opin Support Palliat Care. 2017;11(2):88-92. 28306568 10.1097/SPC.0000000000000262
6. Martinez V Derivaux B Beloeil H: Ketamine for pain management in France, an observational survey. Anaesth Crit Care Pain Med. 2015;34(6):357-61. 26541218 10.1016/j.accpm.2015.04.005
7. Schüttler J Stanski DR White PF: Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. J Pharmacokinet Biopharm. 1987;15(3):241-53. 3668802 10.1007/BF01066320
8. van Velzen M Dahan A: Ketamine metabolomics in the treatment of major depression. Anesthesiology. 2014;121(1):4-5. 24936919 10.1097/ALN.0000000000000286
9. Peltoniemi MA Hagelberg NM Olkkola KT: Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy. Clin Pharmacokinet. 2016;55(9):1059-77. 27028535 10.1007/s40262-016-0383-6 F1000 Recommendation
10. Kronenberg RH: Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration. J Pain Palliat Care Pharmacother. 2002;16(3):27-35. 14640353 10.1080/J354v16n03_03
11. Jonkman K Duma A Velzen M: Ketamine inhalation. Br J Anaesth. 2017;118(2):268-9. 28100533 10.1093/bja/aew457
12. Sigtermans M Dahan A Mooren R: S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. Anesthesiology. 2009;111(4):892-903. 19741495 10.1097/ALN.0b013e3181b437b1
13. Mitchell AC: Generalized hyperalgesia and allodynia following abrupt cessation of subcutaneous ketamine infusion. Palliat Med. 1999;13(5):427-8. 10659115 10.1191/026921699667559279
14. Dahan A Olofsen E Sigtermans M: Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain. Eur J Pain. 2011;15(3):258-67. 20638877 10.1016/j.ejpain.2010.06.016
15. Collino M Thiemermann C Cerami A: Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin. Pharmacol Ther. 2015;151:32-40. 25728128 10.1016/j.pharmthera.2015.02.005 F1000 Recommendation
16. Brines M Dunne AN van Velzen M: ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Mol Med. 2015;20:658-66. 25387363 4365069
17. Culver DA Dahan A Bajorunas D: Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain. Invest Ophthalmol Vis Sci. 2017;58(6):BIO52-BIO60. 28475703 10.1167/iovs.16-21291
18. Niesters M Khalili-Mahani N Martini C: Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers. Anesthesiology. 2012;117(4):868-77. 22890117 10.1097/ALN.0b013e31826a0db3 F1000 Recommendation
19. Niesters M Aarts L Sarton E: Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of-concept study. Br J Anaesth. 2013;110(6):1010-6. 23384733 10.1093/bja/aes578
20. Bell RF: Ketamine for chronic non-cancer pain. Pain. 2009;141(3):210-4. 19128879 10.1016/j.pain.2008.12.003
21. Lee EN Lee JH: The Effects of Low-Dose Ketamine on Acute Pain in an Emergency Setting: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(10):e0165461. 27788221 10.1371/journal.pone.0165461 5082866 F1000 Recommendation
22. Motov S Rosenbaum S Vilke GM: Is There a Role for Intravenous Subdissociative-Dose Ketamine Administered as an Adjunct to Opioids or as a Single Agent for Acute Pain Management in the Emergency Department? J Emerg Med. 2016;51(6):752-7. 27693070 10.1016/j.jemermed.2016.07.087 F1000 Recommendation
23. Sin B Ternas T Motov SM: The use of subdissociative-dose ketamine for acute pain in the emergency department. Acad Emerg Med. 2015;22(3):251-7. 25716117 10.1111/acem.12604
24. Jennings PA Cameron P Bernard S: Ketamine as an analgesic in the pre-hospital setting: a systematic review. Acta Anaesthesiol Scand. 2011;55(6):638-43. 21574967 10.1111/j.1399-6576.2011.02446.x
25. Duncan C Riley B: BET 2: Low-dose ketamine for acute pain in the ED. Emerg Med J. 2016;33(12):892-3. 27864394 10.1136/emermed-2016-206440.2
26. Michelet D Hilly J Skhiri A: Opioid-Sparing Effect of Ketamine in Children: A Meta-Analysis and Trial Sequential Analysis of Published Studies. Paediatr Drugs. 2016;18(6):421-33. 27688125 10.1007/s40272-016-0196-y
27. Assouline B Tramèr MR Kreienbühl L: Benefit and harm of adding ketamine to an opioid in a patient-controlled analgesia device for the control of postoperative pain: systematic review and meta-analyses of randomized controlled trials with trial sequential analyses. Pain. 2016;157(12):2854-64. 27780181 10.1097/j.pain.0000000000000705 F1000 Recommendation
28. Wang L Johnston B Kaushal A: Ketamine added to morphine or hydromorphone patient-controlled analgesia for acute postoperative pain in adults: a systematic review and meta-analysis of randomized trials. Can J Anaesth. 2016;63(3):311-25. 26659198 10.1007/s12630-015-0551-4 F1000 Recommendation
29. Mayhood J Cress K: Effectiveness of ketamine gargle in reducing postoperative sore throat in patients undergoing airway instrumentation: a systematic review. JBI Database System Rev Implement Rep. 2015;13(9):244-78. 26470672 F1000 Recommendation
30. Cho HK Kim KW Jeong YM: Efficacy of ketamine in improving pain after tonsillectomy in children: meta-analysis. PLoS One. 2014;9(6):e101259. 24979227 10.1371/journal.pone.0101259 4076328
31. Ding X Jin S Niu X: Morphine with adjuvant ketamine versus higher dose of morphine alone for acute pain: a meta-analysis. Int J Clin Exp Med. 2014;7(9):2504-10. 25356103 4211753
32. Tong Y Ding X Wang X: Ketamine peritonsillar infiltration during tonsillectomy in pediatric patients: An updated meta-analysis. Int J Pediatr Otorhinolaryngol. 2014;78(10):1735-41. 25139134 10.1016/j.ijporl.2014.07.036
33. Yang L Zhang J Zhang Z: Preemptive analgesia effects of ketamine in patients undergoing surgery. A meta-analysis. Acta Cir Bras. 2014;29(12):819-25. 25517496 10.1590/S0102-86502014001900009
34. Mathews TJ Churchhouse AM Housden T: Does adding ketamine to morphine patient-controlled analgesia safely improve post-thoracotomy pain? Interact Cardiovasc Thorac Surg. 2012;14(2):194-9. 22159259 10.1093/icvts/ivr081 3279980 F1000 Recommendation
35. Dahmani S Michelet D Abback P: Ketamine for perioperative pain management in children: a meta-analysis of published studies. Paediatr Anaesth. 2011;21(6):636-52. 21447047 10.1111/j.1460-9592.2011.03566.x
36. Laskowski K Stirling A McKay WP: A systematic review of intravenous ketamine for postoperative analgesia. Can J Anaesth. 2011;58(10):911-23. 21773855 10.1007/s12630-011-9560-0
37. Bell RF Dahl JB Moore RA: Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev. 2006; (1):CD004603. 16437490 10.1002/14651858.CD004603.pub2
38. Elia N Tramèr MR: Ketamine and postoperative pain--a quantitative systematic review of randomised trials. Pain. 2005;113(1-2):61-70. 15621365 10.1016/j.pain.2004.09.036
39. Subramaniam K Subramaniam B Steinbrook RA: Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg. 2004;99(2):482-95, table of contents. 15271729 10.1213/01.ANE.0000118109.12855.07
40. Klatt E Zumbrunn T Bandschapp O: Intra- and postoperative intravenous ketamine does not prevent chronic pain: A systematic review and meta-analysis. Scand J Pain. 2015;7:42-54. 10.1016/j.sjpain.2014.12.005 F1000 Recommendation
41. McNicol ED Schumann R Haroutounian S: A systematic review and meta-analysis of ketamine for the prevention of persistent post-surgical pain. Acta Anaesthesiol Scand. 2014;58(10):1199-213. 25060512 10.1111/aas.12377
42. Maher DP Chen L Mao J: Intravenous Ketamine Infusions for Neuropathic Pain Management: A Promising Therapy in Need of Optimization. Anesth Analg. 2017;124(2):661-74. 28067704 10.1213/ANE.0000000000001787 F1000 Recommendation
43. Connolly SB Prager JP Harden RN: A systematic review of ketamine for complex regional pain syndrome. Pain Med. 2015;16(5):943-69. 25586192 10.1111/pme.12675 F1000 Recommendation
44. Noppers I Niesters M Aarts L: Ketamine for the treatment of chronic non-cancer pain. Expert Opin Pharmacother. 2010;11(14):2417-29. 20828267 10.1517/14656566.2010.515978
45. Blonk MI Koder BG van den Bemt PM: Use of oral ketamine in chronic pain management: a review. Eur J Pain. 2010;14(5):466-72. 19879174 10.1016/j.ejpain.2009.09.005
46. Bredlau AL Thakur R Korones DN: Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature. Pain Med. 2013;14(10):1505-17. 23915253 10.1111/pme.12182
47. Bell RF Eccleston C Kalso EA: Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2012;11:CD003351. 23152217 10.1002/14651858.CD003351.pub2 F1000 Recommendation
48. Niesters M Dahan A: Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain. Expert Opin Drug Metab Toxicol. 2012;8(11):1409-17. 22871026 10.1517/17425255.2012.712686
49. MacKintosh D: Ketamine and cancer pain - an inconvenient truth? Ann Palliat Med. 2012;1(3):224-6. 25841519 10.3978/j.issn.2224-5820.2012.10.12
50. Oudejans L van Velzen M Olofsen E: Translation of random painful stimuli into numerical responses in fibromyalgia and perioperative patients. Pain. 2016;157(1):128-36. 26307857 10.1097/j.pain.0000000000000338
51. Torensma B Oudejans L van Velzen M: Pain sensitivity and pain scoring in patients with morbid obesity. Surg Obes Relat Dis. 2017;13(5):788-95. 28216116 10.1016/j.soard.2017.01.015
52. Tuttle AH Tohyama S Ramsay T: Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain. 2015;156(12):2616-26. 26307858 10.1097/j.pain.0000000000000333